Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3100 Neoplasms 2446 Carcinoma, Non-Small-Cell Lung 1865 Prostatic Neoplasms 1629 Colorectal Neoplasms 1424 Lung Neoplasms 1300 Multiple Myeloma 930 Neoplasm Metastasis 926 Leukemia, Myeloid, Acute 874 Pancreatic Neoplasms 851 Ovarian Neoplasms 803 Melanoma 786 Carcinoma, Hepatocellular 743 Stomach Neoplasms 640 Brain Neoplasms 640 Recurrence 635 Squamous Cell Carcinoma of Head and Neck 631 Head and Neck Neoplasms 614 Glioblastoma 569 Lymphoma 543 Uterine Cervical Neoplasms 541 Triple Negative Breast Neoplasms 505 Precursor Cell Lymphoblastic Leukemia-Lymphoma 498 Carcinoma, Renal Cell 497 Hematologic Neoplasms 467 Urinary Bladder Neoplasms 462 Endometrial Neoplasms 462 Colonic Neoplasms 439 Sarcoma 437 Lymphoma, Non-Hodgkin 437

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × 1 year × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡